What is Acadia Pharmaceuticals's R&D?

Acadia Pharmaceuticals (ACAD) reported R&D of $76.87M in Q1 2026.

How has Acadia Pharmaceuticals's R&D changed year-over-year?

Acadia Pharmaceuticals's R&D decreased by 1.8% year-over-year, from $78.27M to $76.87M.

What is the long-term trend for Acadia Pharmaceuticals's R&D?

Over 4 years (2021 to 2025), Acadia Pharmaceuticals's R&D has grown at a 8.3% compound annual growth rate (CAGR), from $239.42M to $328.8M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Acadia Pharmaceuticals ACAD R&D

R&D at other companies

BiogenBIIB

$539M+24.2%

Neurocrine BiosciencesNBIX

$296.2M+12.5%

Catalyst PharmaceuticalCPRX

$2.66M-31.5%

PTC TherapeuticsPTCT

$100.87M-7.4%

BridgeBio PharmaBBIO

$126.64M+13.6%

TG TherapeuticsTGTX

$48.4M+4.4%

Segments

By segment

See full

Reportable Segment Aggregation Before Other Operating$76.87M-1.8%

Other financials

Income statement

See full

Revenue$268.1M+9.7%

Gross profit$243.3M+8.6%

Operating income-$4.6M-124%

Net income$3.6M-80.8%

EPS (diluted)$0.02-81.8%

Balance sheet

See full

Cash & equivalents$282.2M+29.6%

Total debt$50.8M-9.3%

Total equity$1.2B+63.1%

Total assets$1.6B+41.8%

Cash flow

See full

Operating cash flow$34.0M+67.2%

CapEx$5.2M—

Free cash flow$28.8M+41.6%

Valuation

See full

Market cap$3.7B+37.0%

Enterprise value$3.47B+36.6%

P/E9.9×-2.0×

P/S3.4×+0.7×

Profitability

See full

Gross margin91.5%-0.6pp

Operating margin7.4%-16.2pp

Net margin34.3%+11.3pp

FCF margin18.9%—

Returns & leverage

See full

Return on equity37.3%+0.1pp

Debt / equity0×0.0×

Current ratio3.6×+0.7×

Where this comes from

Reported directly by Acadia Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Acadia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Acadia Pharmaceuticals's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Acadia Pharmaceuticals's R&D?: Acadia Pharmaceuticals (ACAD) reported R&D of $76.87M in Q1 2026.
How has Acadia Pharmaceuticals's R&D changed year-over-year?: Acadia Pharmaceuticals's R&D decreased by 1.8% year-over-year, from $78.27M to $76.87M.
What is the long-term trend for Acadia Pharmaceuticals's R&D?: Over 4 years (2021 to 2025), Acadia Pharmaceuticals's R&D has grown at a 8.3% compound annual growth rate (CAGR), from $239.42M to $328.8M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.